About this trial
The aim of the project is to collect pre-procedural CT scans, intra-procedural post-evacuation scans as well as immediate post-procedural CT scans to evaluate and collect feedback of two Siemens prototypes: 1) perfusion prototype and 2) automatic hemorrhage detection prototype. The assessment of the prototypes, including its features will focus on the feasibility, usefulness as well as the potential clinical value add in minimally invasive ICH treatment.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient ≥ 18 years old
Patient is planned to undergo minimally invasive hemorrhage evacuation at Mount Sinai West Hospital
Disqualifiers
Patient is < 18 years old
Patient is not planned to undergo minimally invasive hemorrhage evacuation at Mount Sinai West Hospital
Trial design
Single group
Treatments tested in this trial
DynaCT Multiphase
DeviceDynaCT Multiphase device is the perfusion prototype scan. DynaCT Multiphase scans taken intra-operatively will be processed offsite on Siemens' hemorrhage detection and perfusion prototypes.
DynaCT Sine Spin
DeviceDynaCT Sine Spin scan is the automatic hemorrhage detection prototype. Scans taken intra-operatively will be processed offsite on Siemens' hemorrhage detection and perfusion prototypes.
Treatment groups
Trial outcomes
Primary outcomes
Volume of Post-procedure hemorrhage
Quantitative assessment of the comparison of the detected residual hemorrhage on the DynaCT Sine Spin data and the detected residual hematoma on the immediate post-procedural CT
Secondary outcomes
Quantitative correlation outcomes of post-procedure hemorrhage
Correlation of the generated perfusion maps (CBV, CBF, MTT, TTP) to other available clinical information. Prespecified variables to be included are; Location of hypoperfusion on FPCT-PI (1-frontal, 2-parietal, 3-temporal, 4-occipital) and presence of residual hypoperfusion on FPCT-PI (1-present, 2-absent).
Qualitative assessment of the contours of post-procedure hemorrhage
Qualitative assessment of the contours on DynaCT Sine Spin vs postprocedural CT of the hemorrhage detection prototype, using the following scale for evaluation: 1=Clinically usable, 2=Usable with minor edits, 3=Usable with major edits, 4=Redo completely.
Volume of Pre-procedure hemorrhage
Quantitative assessment of the comparison of the detected residual hemorrhage on the DynaCT Sine Spin data and the detected hematoma on the pre-procedural CT
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Icahn School of Medicine at Mount Sinai
Lead sponsor
Siemens Corporation, Corporate Technology
Collaborator